Results

Veradermics Inc.

04/27/2026 | Press release | Archived content

Study 302 Phase 2/3 Topline Results Presentation (April 27, 2026)

Veradermics Inc. published this content on April 27, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 30, 2026 at 14:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]